COMMUNIQUÉS West-GlobeNewswire

Spectral Medical Announces Second Quarter 2026 Financial Results and Provides Corporate Update
07/08/2026
TORONTO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
SAN DIEGO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
Financière de Tubize - Rapport financier semestriel 2026
07/08/2026
Rapport financier semestriel 2026 Information réglementée - 1 août 2026 Le conseil d’administration de la Financière de Tubize a établi le rapport financier semestriel 2026. Ce rapport est disponible sur le site [...]
Financière de Tubize - 2026 half-year financial report
07/08/2026
Half-year financial report 2026 Regulated information 1 August 2026 The board of directors of Financière de Tubize has established the 2026 half-year report. This report is available on the website www.financiere-tubize [...]
Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
07/08/2026
Revenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global Market Under the [...]
Earth Science Tech, Inc. (ETST) Reports Fiscal First Quarter 2027 Financial Results for the Period Ended June 30, 2026
07/08/2026
Net income grew 57% year-over-year to $715,697, with diluted EPS tripling to $0.003 Net c ash provided by operating activities grew 108% to $707,131 All key operating subsidiaries profitable Repurchased and retired 3.7 [...]
Humacyte To Announce 2026 Second Quarter Financial Results and Provide Business Update on August 12, 2026
07/08/2026
DURHAM, N.C., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
07/08/2026
HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd . (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
DALLAS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026
BRISBANE, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co- [...]
Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026
07/08/2026
ASHBURN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
07/08/2026
VALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it will be [...]
Vireo Growth Announces Asset Based Credit Facility
07/08/2026
Facility enhances financial flexibility and supports continued execution of the Company's disciplined growth strategy MINNEAPOLIS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” [...]
CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The PSP Trial Platform (PTP), a landmark clinical trial testing multiple drugs simultaneously in the search for effective PSP treatments, has enrolled its first participant. [...]
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
07/08/2026
ChemoMetec A/S announces its Annual Report for the financial year 2025/26 on Thursday, 10 September, 2026. Following the announcement ChemoMetec A/S will host a conference call on Friday, 11 September, 2026, at 3:00 p.m [...]
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
07/08/2026
-- Potential proceeds would be received upon full cash exercise of warrants -- ATLANTA, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility [...]
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity [...]
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The PSP Trial Platform (PTP), a landmark clinical trial testing multiple drugs simultaneously in the search for effective PSP treatments, has enrolled its first participant. [...]

Pages